Martin Shkreli Quotes


It doesn't seem like life will change very much for Martin Shkreli, basically ever.


Citations

Conti, Allie. "We Spoke to Martin Shkreli About That Wu-Tang Album and Why He Might Buy Fetty Wap's Next Record." Vice, Vice Media, 10 Dec. 2015.

Related Quotes

Roosevelt was on a crusade to eliminate the vicious monopolies and trusts of the time. The number of terms he used to describe them was large but this has become the most memorable and most frequently quoted. See {585244} for some of the other terms he used. While this phrase was original with FDR, his relative, Theodore Roosevelt, used the term “malefactors” in a similar meaning in {585244}.


The term “rugged individualism” was used at the time be very conservatives and the very wealthy to describe business leladers with words that had very good public connotations. They argued that it would be undesirable to curtail their individualism that was so important by any government regulations or laws that would limit what the business leaders could do. However, the reality was that these very successful and powerful “rugged individualists” had regimented most everyone else—employees, consumers, and small businessmen who might sell them services or products. To Tugwell, if the wealthy and powerful few had no restrictions on their individualism, there would be precious little individualism for most of society. He sought a balance of regulating the individualism and prerogatives of the few somewhat in order to allow the vast majority of people to be able to have individuality as well.


Martin Shkreli
Martin Shkreli
  • Born: March 17, 1983
  • Nationality: American
  • Profession: Co-founder MSMB Capital Management, Co-founder Former CEO Retrophin, Founder Former CEO Turing Pharmaceuticals

Martin Shkreli, called "Pharma Bro" by some media, is an American former hedge fund manager and convicted felon. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare; the co-founder and former chief executive officer (CEO) of the pharmaceutical firms Retrophin and Turing Pharmaceuticals (now Vyera Pharmaceuticals); and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.